Αποτελέσματα Αναζήτησης
17 Απρ 2024 · CDC recommends testing blood for lead exposure. A patient’s blood lead level (BLL) is measured in micrograms of lead per deciliter of blood (μg/dL). Healthcare providers should follow recommendations based on initial screening capillary and confirmed venous BLLs. Learn more about the recommended actions after a blood lead level test.
- Risk Factors and Pregnancy
Lead in the blood during pregnancy. Lead in the blood during...
- Risk Factors and Pregnancy
1 Δεκ 2021 · These Guidelines for the Identification and Management of Lead Exposure in Pregnant and Lactating Women are based on scientific data and practical considerations regarding preventing lead exposure during pregnancy, assessment and blood lead testing during pregnancy, medical and environmental management to reduce fetal exposure, breastfeeding, an...
Elevated lead levels in pregnancy have been associated with gestational hypertension, spontaneous abortion, low birth weight, and impaired neurodevelopment. Prenatal lead exposure has known adverse effects on maternal health and infant outcomes across a wide range of maternal blood lead levels.
2 Απρ 2024 · Lead in the blood during pregnancy. Lead in the blood during pregnancy can: Increase risk for miscarriage. Cause the baby to be born too early or too small. Hurt the baby's brain, kidneys, and nervous system. Cause the child to have learning or behavior problems.
Use of a pregnancy-specific questionnaire to perform risk-factor based screening for elevated lead identifies parturients with elevated blood lead levels with good sensitivity but poor specificity.
16 Απρ 2019 · In pregnant women, lead exposure can impair organ systems such as the hematopoietic, hepatic, renal, and nervous systems, and increase the risk of preeclampsia and adverse perinatal outcomes. Many of the adverse health effects of lead exposure are irreversible.
27 Οκτ 2021 · The WHO Guideline for Clinical Management of Exposure to Lead recommends a blood lead concentration of 5 micrograms per decilitre (μg/dL) as a trigger for a thorough review of the ways in which a person is being exposed to lead and for action to reduce or end this exposure.
